Mahathir Bayena

Island Pharmaceuticals (ASX:ILA) has partnered with the Burnet Institute to expand its antiviral pipeline, targeting measles, chikungunya, and the Ross River virus.

Amplitude Energy (ASX:AEL) revealed that flow testing is set to commence at the Isabella prospect following highly encouraging preliminary results.

AbbVie (NYSE:ABBV) shares are in focus after the biopharmaceutical giant released positive topline results for its investigational obesity treatment, ABBV-295.

Nayax (NASDAQ:NYAX) reported fourth-quarter earnings on Monday that cleared Wall Street’s profitability hurdles, even as revenue narrowly missed consensus estimates.

Dianthus Therapeutics (NASDAQ:DNTH) is accelerating the development of its lead immunology candidate after an interim analysis of its Phase 3 CAPTIVATE trial yielded positive results earlier than anticipated.

Korn Ferry (NYSE:KFY) reported a strong third quarter for fiscal 2026, with fee revenue reaching $717.4 million as the global consulting firm successfully leveraged high-growth digital services and long-term contracts to offset broader economic shifts.

Woodward signed a definitive agreement on Monday to acquire Florida-based Valve Research & Manufacturing Company, a move designed to deepen the industrial giant’s component density on both current and future-generation aircraft platforms.

Flow Foundation and parent company Dapper Labs have filed a motion with the Seoul Central District Court to suspend plans by three South Korean exchanges to delist the FLOW token.

Tesla’s early $1.5 billion bitcoin investment generated significant profits before the company sold most of its holdings during the 2022 crypto market downturn, according to blockchain analysis from Arkham.

Starcloud is preparing to launch a satellite designed to mine Bitcoin in low-Earth orbit later in 2026 as part of its plan to build space-based computing infrastructure.